hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC
Authors:
- Paola TronoPTPaola Trono
- Annalisa TocciAnnalisa Tocci
- Belinda PalermoBPBelinda Palermo
- Anna Di CarloACAnna Di Carlo
- Lorenzo D'AMbrosioLDLorenzo D'AMbrosio
- Daniel D'ANdreaDDDaniel D'ANdrea
- Francesca Di ModugnoFMFrancesca Di Modugno
- Francesca De NicolaFNFrancesca De Nicola
- Frauke GoemanFGFrauke Goeman
- Giacomo CorleoneGCGiacomo Corleone
- Sarah WarrenSWSarah Warren
- Francesca PaoliniFPFrancesca Paolini
Open Access
- 23 August 2023
- journal article
- research article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 11 (8) , e006913
Abstract
Background: Understanding how cancer signaling pathways promote an immunosuppressive program which sustains acquired or primary resistance to immune checkpoint blockade (ICB) is a crucial step in improving immunotherapy efficacy. Among the pathways that can affect ICB response is the interferon (IFN) pathway that may be both detrimental and beneficial. The immune sensor retinoic acid-inducible gene I (RIG-I) induces IFN activation and secretion and is activated by actin cytoskeleton disturbance. The actin cytoskeleton regulatory protein hMENA, along with its isoforms, is a key signaling hub in different solid tumors, and recently its role as a regulator of transcription of genes encoding immunomodulatory secretory proteins has been proposed. When hMENA is expressed in tumor cells with low levels of the epithelial specific hMENA11a isoform, identifies non-small cell lung cancer (NSCLC) patients with poor prognosis. Aim was to identify cancer intrinsic and extrinsic pathways regulated by hMENA11a downregulation as determinants of ICB response in NSCLC. Here, we present a potential novel mechanism of ICB resistance driven by hMENA11a downregulation. Methods: Effects of hMENA11a downregulation were tested by RNA-Seq, ATAC-Seq, flow cytometry and biochemical assays. ICB-treated patient tumor tissues were profiled by Nanostring IO 360 Panel enriched with hMENA custom probes. OAK and POPLAR datasets were used to validate our discovery cohort. Results: Transcriptomic and biochemical analyses demonstrated that the depletion of hMENA11a induces IFN pathway activation, the production of different inflammatory mediators including IFNβ via RIG-I, sustains the increase of tumor PD-L1 levels and activates a paracrine loop between tumor cells and a unique macrophage subset favoring an epithelial-mesenchymal transition (EMT). Notably, when we translated our results in a clinical setting of NSCLC ICB-treated patients, transcriptomic analysis revealed that low expression of hMENA11a, high expression of IFN target genes and high macrophage score identify patients resistant to ICB therapy. Conclusions: Collectively, these data establish a new function for the actin cytoskeleton regulator hMENA11a in modulating cancer cell intrinsic type I IFN signaling and extrinsic mechanisms that promote protumoral macrophages and favor EMT. These data highlight the role of actin cytoskeleton disturbance in activating immune suppressive pathways that may be involved in resistance to ICB in NSCLC.Keywords
Funding Information
- AIRC Fellowships Italy 2021 (Project code 26875)
- Associazione Italiana per la Ricerca sul Cancro (IG N° 19822)
- Alleanza Contro il Cancro (RCR-2019 –23669120)
This publication has 58 references indexed in Scilit:
- Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumorsProceedings of the National Academy of Sciences, 2012
- TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRPOncogene, 2011
- An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transitionThe EMBO Journal, 2010
- Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1Biochemical Pharmacology, 2009
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- EMT, the cytoskeleton, and cancer cell invasionCancer and Metastasis Reviews, 2009
- Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancerProceedings of the National Academy of Sciences, 2008
- Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397Journal of Cell Science, 2005
- Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanomaOncogene, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004